Income Statement (TTM)
Glucose Health, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
|
|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 | 1 | 1 |
| Change (%) | 98.39 | -2.48 | 8.27 | 10.50 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 14.94 | -4.55 | 8.06 | 1.42 | |
| % of Revenue | 173.04 | 100.25 | 98.12 | 97.93 | 89.88 |
| Gross Operating Profit | -0 | -0 | 0 | 0 | 0 |
| Change (%) | -99.31 | -823.87 | 19.47 | 439.72 | |
| % of Revenue | -73.04 | -0.25 | 1.88 | 2.07 | 10.12 |
| SG&A | 0 | 0 | 1 | 1 | 0 |
| Change (%) | 22.14 | 66.75 | -7.15 | -9.30 | |
| % of Revenue | 56.84 | 34.99 | 59.83 | 51.31 | 42.11 |
| R&D | |||||
| Change (%) | |||||
| % of Revenue | |||||
| OpEx | 1 | 1 | 1 | 2 | 1 |
| Change (%) | 16.72 | 13.90 | 2.30 | -2.27 | |
| % of Revenue | 229.88 | 135.24 | 157.95 | 149.24 | 131.99 |
| Operating Income | -1 | -0 | -1 | -0 | -0 |
| Change (%) | -46.17 | 60.36 | -8.01 | -28.20 | |
| % of Revenue | -129.88 | -35.24 | -57.95 | -49.24 | -31.99 |
| Interest Expense | -0 | -0 | -0 | 0 | 0 |
| Change (%) | -84.32 | -50.34 | -100.00 | NaN | |
| % of Revenue | -3.69 | -0.29 | -0.15 | 0.00 | 0.00 |
| Net Income | -0 | -0 | -1 | -0 | -0 |
| Change (%) | -29.05 | 59.45 | -8.25 | -28.20 | |
| % of Revenue | -99.37 | -35.54 | -58.10 | -49.24 | -31.99 |
Source: Capital IQ
